Precision Business Insights has published a report on the global oligonucleotide synthesis market, estimating its value at USD 8.8 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 17.5% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/oligonucleotide-synthesis-market      

The market refers to the global industry involved in the production and commercialization of short DNA or RNA sequences called oligonucleotides that are used in research, diagnostics, and therapeutics. These synthetic strands play a crucial role in areas like genetic testing, drug development, and molecular biology.

Key Drivers:
Increasing adoption of oligonucleotides in therapeutics & diagnostics
Rising use of antisense oligonucleotides, siRNA, aptamers, and CRISPR-based therapies is boosting demand.

Growing investment in genetic & genomic research
Expanding R&D in genomics, molecular biology, and precision medicine is driving need for custom oligos.

Rise in synthetic biology and drug discovery activities
Pharmaceutical & biotech companies are increasingly using synthesized oligos for target validation and drug development.

Advancements in synthesis technologies
Automated platforms, enzymatic synthesis, and improved chemistries are enabling faster, high-fidelity, and cost-effective oligonucleotide production.

The global oligonucleotide synthesis market segmentation:
1) By Product Type: Reagents, Equipment, Services
2) By Nucleic Acid Type: DNA, RNA
3) By Applications: Therapeutic, Research, Diagnostic
4) By End User: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, Academic Research Institutes

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=23376

Regional Overview:
The report also examines the current concerns and their Future Effects on the oligonucleotide synthesis market by region. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

• North America (U.S., Canada)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
• Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
• Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like Integrated DNA Technologies, Inc., GenScript, Eurofins Scientific SE, Bioneer Corporation, Kaneka Corporation (Eurogentec), Biolegio B.V., Eton Bioscience, Inc., IBA GmbH, Quintara Biosciences, LGC Biosearch Technologies  

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747